Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- XRTX
- Price
- 0.90
- Stock movement down
- -0.02 (-1.89%)
- Company name
- XORTX Therapeutics Inc
- Exchange
- (NASDAQ ,
- Currency
- USD )
- Sector
- Healthcare >Biotechnology
- Market cap
- 2.91M
- Ent value
- 2.33M
- Price/Sales
- -
- Price/Book
- 1.37
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- -29.82%
- 1 year return
- -72.20%
- 3 year return
- -62.67%
- 5 year return
- -
- 10 year return
- -
Last updated: 2025-04-05
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
DIVIDENDS
XRTX does not pay dividends or no data was received
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | - |
| Price to Book | 1.37 |
| EV to Sales | - |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 3.22M |
| EPS (TTM) | -0.25 |
| FCF per share (TTM) | -1.44 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 0.00 |
| Gross profit (TTM) | -109.55K |
| Operating income (TTM) | -6.86M |
| Net income (TTM) | -736.66K |
| EPS (TTM) | -0.25 |
| EPS (1y forward) | - |
Margins
Loading...
Margins data
| Gross margin (TTM) | - |
| Operating margin (TTM) | - |
| Profit margin (TTM) | - |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 2.30M |
| Net receivables | 13.11K |
| Total current assets | 2.41M |
| Goodwill | 0.00 |
| Intangible assets | 185.70K |
| Property, plant and equipment | 0.00 |
| Total assets | 3.85M |
| Accounts payable | 110.74K |
| Short/Current long term debt | 61.47K |
| Total current liabilities | 1.72M |
| Total liabilities | 1.72M |
| Shareholder's equity | 2.13M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -4.09M |
| Capital expenditures (TTM) | 44.68K |
| Free cash flow (TTM) | -4.17M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | -34.53% |
| Return on Assets | -19.13% |
| Return on Invested Capital | -33.56% |
| Cash Return on Invested Capital | -190.04% |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 0.92 |
| Daily high | 0.95 |
| Daily low | 0.85 |
| Daily Volume | 18K |
| All-time high | 60.39 |
| 1y analyst estimate | 12.17 |
| Beta | -0.21 |
| EPS (TTM) | -0.25 |
| Dividend per share | - |
| Ex-div date | - |
| Next earnings date | 14 May 2025 |
Downside potential
Loading...
Downside potential data
| XRTX | S&P500 | |
| Current price drop from All-time high | -98.50% | -17.56% |
| Highest price drop | -98.64% | -56.47% |
| Date of highest drop | 21 Feb 2025 | 9 Mar 2009 |
| Avg drop from high | -75.94% | -11.07% |
| Avg time to new high | 88 days | 12 days |
| Max time to new high | 899 days | 1805 days |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
COMPANY DETAILS
Marketcap
2.91M
Marketcap category
Small-cap
Description
XORTX Therapeutics Inc., a late stage clinical pharmaceutical company, engages in the development and commercialization of therapies to treat progressive kidney diseases, pre-diabetes, insulin resistance, metabolic syndrome, diabetes, diabetic nephropathy, and infection. It develops XRx-008, a late clinical stage program therapy for autosomal dominant polycystic kidney disease; XRx-101, a program to treat acute kidney injury (AKI) associated with respiratory virus infection and associated health consequences; and XRX-225, a program for treatment of type 2 diabetic nephropathy. It has a collaboration and license agreements with the Icahn School of Medicine; and a license agreement with the University of Florida Research Foundation, Inc. The company is based in Alberta Beach, Canada.
Employees
2
Website
Investor relations
-
SEC filings
CEO
Country
USA
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
Seeking AlphaPress releases
iO Charts is a Seeking Alpha partner